pantothenic acid has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bourgin, M; Kepp, O; Kroemer, G | 1 |
| Benedicto, A; Hernandez-Unzueta, I; Márquez, J; Sanz, E | 1 |
| Bulovskaia, LN | 1 |
3 other study(ies) available for pantothenic acid and Malignant Melanoma
| Article | Year |
|---|---|
Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy.
Topics: Animals; Coenzyme A; Gastrointestinal Microbiome; Humans; Immunologic Factors; Immunotherapy; Melanoma; Mice; Pantothenic Acid | 2022 |
Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Cancer-Associated Fibroblasts; Cell Line, Tumor; Drug Resistance, Neoplasm; Folic Acid; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Pantothenic Acid; Plant Extracts; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Vemurafenib; Vitamin B 12; Vitamin B 6; Zinc Sulfate | 2021 |
[Acetylation reaction in mice in the normal state and in tumors].
Topics: Acetylation; Animals; Female; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasms, Experimental; Pantothenic Acid; Sarcoma, Experimental; Sulfamethazine | 1976 |